EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

TPS63 - Asthma 8

Sunday 02 Jun, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
A case of chronic cough induced by esophageal hypersensitivity
Clinical profile of 457 Latin-American severe asthma patients in Mexico: differences between those who are and those who are not on biologics (OMA, DUPI, anti-IL5)
Efficacy of Dupilumab in patients over 50 years of age with severe asthma
Health Care Situation in the Treatment of Uncontrolled GINA 4/5 Asthma Patients in Germany: 2019 vs. 2022
Insights from Benralizumab Treatment
Lung Function Improvement is Associated With Better Asthma Control in Adolescents and Adults Aged 12 Years and Older With Moderate-to-Severe Type 2 Asthma: A Post Hoc Analysis of QUEST
Real-world effectiveness of biologics in patients with severe asthma: analysis of the Korean Severe Asthma Registry (KoSAR)
Respiratory muscle functions in asthma
Stability of steroid-dependent severe asthma during 5-year follow-up
Subcellular Localization and Differential Effects of TSLP Isoforms on Human Lung Macrophages
The dynein adaptor Hook2 as microtubule-based transport and anchors for organelles is involved in asthma pathogenesis
The impact of Type 2- targeted biological therapies on persistent cough in adults with cough variant- or cough predominant asthma
The parasympathetic nervous system plays a key role in control and stress in patients with asthma

Chairs

Speakers